Glucocorticoid Stimulates Melanogenesis and Tyrosinase Gene Expression in B16 Melanoma Cells
Authors:
- 1 December 1991
- journal article
- Published by Wiley in Pigment Cell Research
- Vol. 4 (5-6) , 247-251
Abstract
Effects of dexamethasone on melanogenesis and tyrosinase mRNA levels were determined in B16/F10 melanoma cells. Melanin content of B16 cells increased in a dose-dependent manner by the addition of dexamethasone to the culture medium. After 72 hr exposure, dexamethasone (10(-6) M) produced a 2.4-fold increase in melanin content. Northern blot analysis revealed that tyrosinase mRNA level also increased by the addition of dexamethasone to the culture medium. After 24 hr exposure, dexamethasone (10(-6) M) caused a 1.8-fold increase in tyrosinase mRNA levels. A tumor promoter, 12-O-tetradecanoyl phorbol-13-acetate (TPA) decreased tyrosinase mRNA level at 30 nM concentration. Dexamethasone antagonized this TPA-mediated decrease in tyrosinase mRNA. It is suggested that glucocorticoids are involved in the regulation of tyrosinase activity at the transcriptional level.Keywords
This publication has 25 references indexed in Scilit:
- Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptorCell, 1990
- Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interactionCell, 1990
- Sequence analysis of mouse tyrosinase cDNA and the effect of melanotropin on its gene expressionBiochemical and Biophysical Research Communications, 1988
- Purified transcription factor AP-1 interacts with TPA-inducible enhancer elementsCell, 1987
- Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factorCell, 1987
- Steroid Hormone Regulation of Gene ExpressionAnnual Review of Pharmacology and Toxicology, 1985
- Immunopathology of vitiligo vulgaris, Sutton's leukoderma and melanoma‐associated vitiligo in relation to steroid effectsJournal of Cutaneous Pathology, 1984
- Steroid hormone receptor studies in melanoma model systemsJournal of Supramolecular Structure, 1980
- A double-blind trial of 0.05% clobetasol proprionate in the treatment of vitiligoBritish Journal of Dermatology, 1977
- Vitiligo – Response to 0.2 % Betamethasone 17-Valerate in Flexible CollodionDermatology, 1970